[CYCC] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
14-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 8.72%
YoY- -36.55%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 0 0 0 0 0 0 139 -
PBT -5,246 -4,165 -1,510 -2,110 -1,531 -1,861 -3,534 6.80%
Tax -1,138 -687 -290 -268 -182 -306 -493 14.95%
NP -4,108 -3,478 -1,220 -1,842 -1,349 -1,555 -3,041 5.13%
Tax Rate - - - - - - - -
Total Cost 4,108 3,478 1,220 1,842 1,349 1,555 3,180 4.35%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -2,187.77 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.41 -0.50 -1.42 -2.70 -2.25 -7.28 -20.51 -47.88%
EPS Diluted -0.41 -0.50 -1.42 -2.70 -2.25 -7.28 -20.51 -47.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.